Wednesday, October 25, 2017

Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY) Experiences Heavy ...

Modern Readers-12 hours ago
The Company, through its Imprimis Cares program, owns, markets and dispenses a portfolio of compounded therapeutic in several therapeutic areas, including ...
Post a Comment